Wednesday, June 28, 2017

AIPM’s Response to FDA’s Request to Pull Opana ER Off Market

On Thursday, June 8, the U.S. Food and Drug Administration “requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market,” the FDA said in a statement. Apparently Opana ER, an extended release form of the opioid drug oxymorphone, was being crushed up and injected by people seeking to

Federal Medicine

Honoring Memorial Day: 4 Online Courses For Veterans and Military Patients with Pain

In honor of Memorial Day, we thought we’d point you to some online courses in our Pain Care Learning Center that might be useful for your patients who are veterans and military. All courses are accredited for physicians, nurses, psychologists and pharmacists: Community-Based Integrative Treatment Programs for Veterans and Military with Post-Traumatic Stress and Chronic

Policy

Virginia Adopts Emergency Opioid and Buprenorphine Prescribing Rules

Effective immediately, Virginia’s Board of Medicine has adopted emergency regulations governing the prescribing of opioids and buprenorphine. These regulations apply to doctors of medicine, osteopathic medicine, and podiatry, and to physician assistants who are treating acute and chronic pain that is not associated with cancer, hospice, palliative care, inpatient hospitals, inpatient nursing homes, or clinical

Policy

New Law Protects West Virginians from Unsafe Step Therapy

We have great news, West Virginians! With the passage of House Bill 2300, patients and prescribing practitioners are guaranteed access to a clear and convenient process to request a step therapy exception determination made easily accessible on the health plan issuer’s or utilization review organization’s website. Further, and of the utmost importance, the new law

28th Annual Meeting 2017

NEW! Now Offering Easy, All-Inclusive Packages for Our 28th Annual Meeting

We are pleased to announce new, all-inclusive packages to attend our 28th Annual Meeting — 2017’s largest meeting dedicated to integrative pain management! These packages are the easiest — and most inexpensive — ways to join thousands of other pain professionals to learn about the newest, evidence-based, integrative approaches to pain management. With just one

Policy

Michigan Expands Access to Care in Rural Areas

Michigan has greatly expanded access to high quality care in rural areas through the use of telehealth, thanks to the recent passage of Senate Bill 213. Signed on 3/29 and effective immediately, the new law allows a health professional to prescribe a controlled substance via telehealth if they comply with both of the following: When

Policy

Utah Makes Extensive Opioid-Related Policy Changes

During what can only be described as a whirlwind of a legislative session, Utah’s legislature adjourned earlier this month after passing more than half a dozen bills addressing opioid medications, many of which will directly affect the way that health care providers may provide care to people living with pain. Please note: New laws in

Policy

Lost In Chaos: The State of Chronic Pain in 2016

Millions of Americans living with chronic pain struggle because two important public health issues— chronic pain and opioid addiction—are misunderstood and have been conflated. Until these two health conditions are properly distinguished, studied and addressed, the problems associated with both will continue. Tension and misunderstanding surrounding chronic pain and opioid addiction characterize the state of

Policy

How Virginia’s New Laws Affect Pain Practices

The Virginia legislature and governor recently approved a number of bills that will affect your practice: Prescription Monitoring Program Requirements Under existing law, a prescriber was required to check the PMP when initiating a new opioid prescription expected to last more than 14 consecutive days. Passage of House Bill 1885 will require that PMP check